Third-generation cephalosporin

200-400 mg/day as a single dose or in 2 divided doses.

Severe respiratory tract infections.
Urinary tract infections (UTIs).
Septicemia.
Intra-abdominal infections.
Bone and joint infections.
Meningitis.
Post-surgical infections.

Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis.